Recipient mice that received cells from donors treated with STAT3 inhibitor displayed impaired tumor growth compared to both mice that receive lymphocytes from control tumor-bearing mice or non-reconstituted RAG1-/- mice (Figure 6C). This evidence concerns the gene STAT3 and neoplasm.